METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

METHODS FOR REGULATING BLOOD GLUCOSE LEVELS

RBP4 in insulin sensitivity/resistance, diabetes, and obesity

TREATMENT OF OBESITY

MARKER PROTEIN FOR TYPE-2 DIABETES

DETECTION OF HEPATIC INSULIN RESISTANCE

Compound accumulating in inflammatory site, diagnostic agent containing the compound in labeled state and its precursor compound for labeling

METHOD OF PROGNOSIS

Anti-interferon-α antibodies

Non-human mammalian animal model for type 2 diabetes

FIBROSIS INHIBITOR

Method for treatment of cachexia by administering inhibitors of adipose triglyceride lipase expression or activity

Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin

Methods of treating diseases

Methods for detecting pre-diabetes and diabetes using differential protein glycosylation

RIP140 regulation of glucose transport

Method and compositions for treating stroke with fever

Methods for detecting pre-diabetes and diabetes using differential protein glycosylation

Methods for detecting pre-diabetes and diabetes using differential protein glycosylation

Biomarkers for monitoring insulin resistance and methods using the same

RAPID SACCHARIDE BIOMARKER ASSAY

Apparatus and method for non-invasively detecting diseases that affect structural properties in biological tissues

Method for insulin resistance improving and a method for prevention or treatment of diabetes

METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES

Tracking the probability for imminent hypoglycemia in diabetes from self-monitoring blood glucose (SMBG) data

CROSS-ß STRUCTURE COMPRISING AMYLOID-BINDING PROTEINS AND METHODS FOR DETECTION OF THE CROSS-ß STRUCTURE, FOR MODULATING CROSS-ß STRUCTURES FIBER FORMATION AND FOR MODULATING CROSS-ß STRUCTURE-MEDIATED TOXICITY

ASSAY FOR DETERMINING HEALTH OF CD8+ T CELLS

Diabetes-related biomarkers and methods of use thereof

BIOMARKERS AND THERAPEUTIC TARGETS FOR TYPE 1 DIABETES

METHOD AND KIT FOR THE CLASSIFICATION AND PROGNOSIS OF WOUNDS

METHOD FOR TEST ON DIABETIC NEPHROPATHY

METHOD FOR INCREASING INSULIN SENSITIVITY AND FOR TREATING AND PREVENTING TYPE 2 DIABETES

Trimethylamine-containing compounds for diagnosis and prediction of disease

Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes

PROCALCITONIN FOR THE PROGNOSIS OF ADVERSE EVENTS

Method of screening a substance for improving insulin resistance

Injection mould having a varying volume mould cavity

Antibodies that bind amyloid oligomers

Antagonists of the Magnesium Binding Defect as Therapeutic Agents and Methods for Treatment of Abnormal Physiological States

METHODS FOR IDENTIFYING, ISOLATING, AND UTILIZING ENDOCRINE PROGENITOR CELLS FROM ADULT HUMAN PANCREAS

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASE

METHOD FOR TREATING CANCER BY INCREASING AMP-ACTIVATED KINASE ACTIVITY

Biomarkers Related to Insulin Resistance and Methods using the Same

METHOD FOR ASSESSING ARTERIOSCLEROSIS AND DIABETIC NEPHROPATHY

Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity

Methods for early detection of blood disorders

Anti-KTPAF50 antibodies and their uses in therapeutic and diagnostic methods

Blood analysis apparatus

METHODS OF DIAGNOSING INSULIN RESISTANCE AND SENSITIVITY

METHOD FOR DIAGNOSING POMPE DISEASE

Biomarkers for differentiating between type 1 and type 2 diabetes

Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG

Method For Detecting And Purifying Pancreatic Beta Cells

METHOD AND APPARATUS FOR ANALYZING VITAMIN E IN LIPOPROTEINS

METHOD OF TREATMENT OF VASCULAR COMPLICATIONS

Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same

Methods for assaying α-L-iduronidase enzymatic activity

IDENTIFICATION, MONITORING AND TREATMENT OF INFECTIOUS DISEASE AND CHARACTERIZATION OF INFLAMMATORY CONDITIONS RELATED TO INFECTIOUS DISEASE USING GENE EXPRESSION PROFILES

Analytical method of hemoglobin

GLYCOPEPTIDE AND USES THEREOF

DIABETES DIAGNOSTIC, PROPHYLACTIC, AND THERAPEUTIC COMPOSITIONS AND METHODS

DIABETIC MODEL

METHODS FOR PANCREATIC TISSUE REGENERATION

Naphthalene-based inhibitors of anti-apoptotic proteins

Diagnostic marker for type 1 diabetes mellitus

Rapidly Dissolving Oral Strip of Sugar for Hypoglycemia

DIAGNOSTIC MARKERS OF WOUND INFECTION

Detection of oligosaccharides

DIFFERENTIATING CARDIAC- AND DIABETES MELLITUS-BASED CAUSES OF KIDNEY DAMAGE

Peptide biomarkers predictive of renal function decline and kidney disease

ENPP1 (PC-1) GENE HAPLOTYPE ASSOCIATED WITH THE RISK OF OBESITY AND TYPE 2 DIABETES AND THEIR APPLICATIONS

Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)

Methods, products and treatments for diabetes

Stabilizing agent for control material, control material containing the stabilizing agent, and measurement kit comprising the control material

Fructosyl peptide oxidase

METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK

5-Ht6 Receptor and Modulators Thereof for the Treatment of Insulin-Related Disorders

Arginine vasopressin pro-hormone as predictive biomarker for diabetes

Compounds having an isolated peptide consisting of structure (I)

Human pancreatic beta cell lines for diagnostic of diabetes

Inositol Pyrophosphates Determine Exocytotic Capacity

Polymer end group detection

MULTIPLEXED BIOMARKERS OF INSULIN RESISTANCE

Methods of Treatment

PROTEIN ISOFORMS FOR DIAGNOSIS

Reagents and methods for detecting a polymorphic protein

METHODS AND COMPOSITIONS FOR THE REGULATION OF LECTIN COMPLEMENT PATHWAY (LCP)-ASSOCIATED COMPLEMENT ACTIVATION IN HYPERGLYCEMIC MYOCARDIAL DAMAGE

Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases

Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

Methods of diagnosing and predicting renal disease

METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS

Screening methods for compounds useful for treating pancreatic dysfunction

BIO-MARKERS FOR DIAGNOSING DIABETIC RETINOPATHY

ANTI-INTERFERON-ALPHA ANTIBODIES

METHOD FOR THE PROGNOSIS AND DIAGNOSIS OF TYPE II DIABETES IN CRITICAL PERSONS

Diagnosis and complication risk assessment of pancreatic diabetes using procalcitonin

Biosensor for electrochemical measurement of 1,5-anhydroglucitol, and measuring method and measuring kit using the same

Biomarkers of Mineralocorticoid Receptor Activation

Method for detecting lysosomal storage diseases

MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES

BIOMARKERS AND ASSAYS FOR DIABETES

Disease-Associated Antigens and Methods of Use Thereof

ApoIII and the treatment and diagnosis of diabetes

Methods and compositions for the diagnosis and treatment of diabetes

Method for treating or preventing a pancreatic dysfunction

NOVEL METHOD FOR PREDICTION OF CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES

METHODS FOR PREDICTING DEVELOPMENT OF AUTO-IMMUNE DISEASES AND TREATMENT OF SAME

Anti-interferon-α antibodies

MANNOSE 6-PHOSPHATE-BINDING ANTIBODIES AND THEIR USES

Method and apparatus for analyzing vitamin E in lipoproteins

TREATMENT OF POMPE DISEASE WITH SPECIFIC PHARMACOLOGICAL CHAPERONES AND MONITORING TREATMENT USING SURROGATE MARkERS

Method and system for measuring a sample to determine the presence of and optionally treat a pathologic condition

Screening Method (Metabolite Grid) for Therapeutic Extracts and Molecules for Diabetes

Methods for Identifying Subjects With an Increased Likelihood of Responding to DPP-IV Inhibitors

TEST METHOD FOR TYPE-2 DIABETES USING GENE POLYMORPHISM

Brown adipocyte progenitors in human skeletal muscle and methods for identifying differentiation agents therefor

TETRAHYDRO-ISOALPHA ACID COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT

TYPE II DIABETES MOLECULAR BIOPROFILE AND METHOD AND SYSTEM OF USING THE SAME

ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR POMPE DISEASE

Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease

Methods for detecting pre-diabetes and diabetes

Kit for diagnosis, prognosis, and monitoring the immune status, of patients with chronic inflammatory diseases

Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

PANCREATIC BETA-CELL MASS BIOMARKER

Disease Specific Diagnostic Aid

Biomarkers for insulin sensitizer drug response

MEANS AND METHODS DIAGNOSING GASTRIC BYPASS AND CONDITIONS RELATED THERETO

THERAPEUTIC AGENTS AND TARGETS

Novel genes and markers in type 2 diabetes and obesity

Novel genes and markers in type 2 diabetes and obesity

Resistin as a Marker and Therapeutic Target for Cardiovascular Disease

Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers

Biomarkers

INSULIN RESISTANCE MARKER

Compositions and Methods for Diagnosing and Treating Insulin Resistance

Prophylactic/therapeutic agents for lifestyle-related diseases

Method and system to provide personalized pharmaceutical compositions and dosages

Biomarkers for diabetes, obesity, and/or hypertension

Inositol Pyrophosphates Determine Exocytotic Capacity

Measuring multiple analytes over a broad range of concentrations using optical diffraction

ASSESSMENT OF COMPLICATIONS OF PATIENTS WITH TYPE 1 DIABETES

Diagnostic gum for screening diabetes

Methods for identifying compounds for the treatment of type 1 diabetes

COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS

METHOD FOR RISK REDUCTION IN GLYCEMIC CONTROL

GENE SIGNATURES

MOLECULES AND METHODS FOR TREATMENT OF DIABETES

Control of Exocrine Pancreatic Function Using Bone Morphogenetic Proteins

METHODS FOR DIAGNOSING DIABETES AND DETERMINING EFFECTIVENESS OF TREATMENTS

Composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it

Predicting renal failure in diabetes patients based on placental growth factor and soluble FLT-1

GDF-15 AS BIOMARKER IN TYPE 1 DIABETES

Method for evaluation or selection of adiponectin secretion regulator

METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10)

Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

ANTI-BRAK (CXCL14) HUMAN MONOCLONAL ANTIBODY AND USE THEREOF

METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

METHODS FOR MEASURING THE INSULIN RECEPTOR ALPHA SUBUNIT

Screening for CD93 (C1qRp)-associated polymorphism(S) in the diagnosis, prevention and treatment of autoimmune diseases

APOLIPOPROTEIN CIII IN PRE- AND TYPE 2 DIABETES

Biomarkers

PHENOTYPIC RATIO OF SERUM AMYLOID IN PRE- AND TYPE 2 DIABETES

COMBINED COMPUTER DEVICE AND FACILITY AIR PURIFICATION

Early detection of diabetes

Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells

HNF4alpha MODULATORS AND METHODS OF USE

Peptides

METHODS FOR IDENTIFYING DIABETES AND OBESITY THERAPEUTICS

METABOLIC FUEL SWITCHING BIOMARKER

Prophylactic or therapeutic agent for diabetic maculopathy

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

PHOSPHOPROTEOMIC EVALUATION OF DIABETES AND OBESITY

T cell receptor having binding affinity for a peptide-MHC complex and uses thereof

PREDICTIVE TREATMENT OF DYSGLYCEMIC EXCURSIONS ASSOCIATED WITH DIABETES MELLITUS

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods for detecting pre-diabetes and diabetes using differential protein glycosylation

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Methods and Kits for Predicting Treatment Response in Type II Diabetes Mellitus Patients

Method for detection of disease having insulin-resistant conditions

Voltage gated calcium channel β-subunit anchoring regulator protein and uses thereof

Structure of the insulin receptor ectodomain

Naphthalene-based inhibitors of anti-apoptotic proteins

Method of evaluating IGT, IGT-evaluating apparatus, IGT-evaluating method, IGT--evaluating system, IGT-evaluating program, recording medium, and method of searching for prophylactic/ameliorating substance for IGT

ANALYSIS APPARATUS AND ANALYSIS METHOD FOR CAPILLARY ELECTROPHORESIS

NOVEL AS160-LIKE PROTEIN, TEST SYSTEMS, METHODS AND USES INVOLVING IT FOR THE IDENTIFICATION OF DIABETES TYPE 2 THERAPEUTICS

METHOD AND MARKER FOR DIAGNOSING DIABETES MELLITUS

Use of Lipocalin 2 in the Regulation of Insulin Sensitivity

Methods and Compositions for Ameliorating Diabetes and Symptoms Thereof

Means and method for predicting diabetes

Plasma anti-diabetic NUCB2 peptide (pladin) and uses thereof

Methods for detection of biological substances

Methods and materials relating to PAQR polypeptides and polynucleotides

Methods for Diagnosing and Treating Endoplasmic Reticulum (ER) Stress Diseases

METHODS OF USING A G PROTEIN-COUPLED RECEPTOR TO IDENTIFY PEPTIDE YY (PYY) SECRETAGOGUES AND COMPOUNDS USEFUL IN THE TREATMENT OF CONDITIONS MODULATED BY PYY

Methods for assaying alpha-L-iduronidase enzymatic activity

Methods of using a G protein-coupled receptor to identify peptide YY (PYY) secretagogues

METABOLIC MARKERS OF DIABETIC CONDITIONS AND METHODS OF USE THEREOF

NOVEL SECRETED PROTEINS OF ADIPOCYTES FOR DIAGNOSTIC PURPOSES

Postprandial hyperglycemia marker, method of measuring the same, and usage thereof

DOG DIABETES

Detection of oligosaccharides

DRAK2 EXPRESSION IS ASSOCIATED WITH DIABETES

Periodic acid-schiff staining with detection in the infrared range

Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease

Method of determining 1,5-anhydroglucitol, and reagent composition for determining 1,5-anhydroglucitol

Biomarker and Method for Determining an Oxidative Stress Level

Quantification of non-reducing end glycan residual compounds

Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes

FIBROSIS INHIBITOR

Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress

Diagnostic markers of wound infection

Means and method for diagnosing diabetes

Methods of modulating metabolic memory

Method of conducting a droplet based enzymatic assay

Methods using PBK1 for identifying agents that treat metabolic disorders

Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics

In vitro assay for early diagnosis of diabetes mellitus type 1

Diagnostic and therapeutic target for autoimmune diseases and uses thereof

Method of treating diabetes

Prediction and prophylactic treatment of type 1 diabetes

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Biomarkers for cardiodiabetes

Biomarkers for insulin efficacy

Method of treating a subject according to biomarkers for insulin resistance

Glycated Insulin as a Biomarker for Diagnosis and Monitoring of Diabetes

Detection method and detection reagent for autoimmune pancreatitis or fulminant type-1 diabetes

Biomarkers for Differentiating Between Type 1 and Type 2 Diabetes

MODIFIED ROUTES OF LIPID METABOLISM, MEASURING OXIDIZED LDL AFTER FAT LOADING

METHODS OF QUANTIFYING N2-(1-CARBOXYETHYL)-2'-DEOXY-GUANOSINE (CEdG) AND SYNTHESIS OF OLIGONUCLEOTIDES CONTAINING CEdG

RIP140 regulation of diabetes

Remedy for diabetes

Injection moulding method

Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles

METHODS FOR TREATING CACHEXIA AND LYMPHOPENIA

Assay

METHOD AND KITS FOR THE DIAGNOSIS OF DIABETES

Methods and Compositions Related to Inhibition of Ceramide Synthesis

Antagonist of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states

METHOD TO MONITOR DRUG EFFICACY IN DIABETIC PATIENTS USING AN ASSAY FOR 1,5-ANHYDRO-D-GLUCITOL

Enzyme assays for a droplet actuator

METHOD OF PREDICTING A BENEFIT OF ANTIOXIDANT THERAPY FOR PREVENTION OF CARDIOVASCULAR DISEASE IN HYPERGLYCEMIC PATIENTS

DIAGNOSIS AND RISK ASSESSMENT OF PANCREATIC DIABETES USING MR-PROADM

SCREENING METHOD

AMELIORATING AGENT FOR INSULIN RESISTANCE

DIAGNOSIS OF HYPERINSULINEMIA AND TYPE II DIABETES AND PROTECTION AGAINST SAME BASED ON PROTEINS DIFFERENTIALLY EXPRESSED IN SERUM

Method for Evaluating Obesity Controller

Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2

Fluorescent Analogs Of The Islet Amyloid Polypeptide

Timp-2 as target/marker of beta cell failure

RBP4 in insulin sensitivity/resistance, diabetes, and obesity

Treatment of insulin resistance by administering an acid-sensing ion channel 3 inhibitor

METHODS OF DIAGNOSIS AND TREATMENT FOR METABOLIC DISORDERS

System for Glycated Protein Detection

Diagnostic marker for diabetic vascular complications

LEVELS OF BCMA PROTEIN EXPRESSION ON B CELLS AND USE IN DIAGNOSTIC METHODS

Method for quantitative detection of diabetes related immunological markers

BIOFLUID METABOLITE PROFILING AS A TOOL FOR EARLY PREDICTION OF AUTOIMMUNITY AND TYPE 1 DIABETES RISK

Methods for screening for genetic predisposition to type I diabetes

IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics

Methods for identifying a GLP-1 secretagogue

Method of selectively assaying adiponectin multimers

Serum markers for type II diabetes mellitus

Method for detecting lysosomal storage diseases

A Method And A Kit For Diagnosing Type 2 Diabetes, Metabolic Syndrome, Sub Clinical Atherosclerosis, Myocardial Infarct, Stroke Or Clinical Manifestations Of Diabetes

Diabetes-related biomarkers and methods of use thereof

50 Human Secreted Proteins

Methods of using GPR119 to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY

50 Human Secreted Proteins

Method and apparatus for analyzing vitamin E in lipoproteins

METHODS OF USING QUANTITATIVE LIPID METABOLOME DATA

Conditionally-Immortalised Pancreatic Cells

METHOD FOR INDUCTION OF THE DIFFERENTIATION OF VISCERAL FAT CELL

Transgenic pig with altered incretin function

METHODS OF MHC CLASS II EPITOPE MAPPING, DETECTION OF AUTOIMMUNE T CELLS AND ANTIGENS, AND AUTOIMMUNE TREATMENT

Increasing glucose transport and insulin-stimulated glucose uptake

Diabetes Model Animal

Pancreatic polypeptide as target/marker of beta cell failure

PRO1120 polypeptides

Method for identifying diabetic patients at increased risk for pathological complications

Methods for metabolic modulation

Modulation of Peripheral Clocks in Adipose Tissue

Adiponectin for treatment of various disorders

Methods and Kit for Diagnosing T1DM

Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems

Chemokine antagonists as treatment for obesity-related and metabolic syndrome-related conditions

Method and index for diagnosing insulin resistance

Methods, products and treatments for diabetes

Bio-Markers For Diagnosing Diabetic Retinopathy

TRANSCRIPTION FACTOR ARNTL2 GENE AND EXPRESSION PRODUCTS THEREOF USED IN THE DIAGNOSIS, PREVENTION, AND TREATMENT OF TYPE 1 DIABETES

Method for determining the concentration of the adipocytic form of the fatty acid binding protein (A-FABP, FABP4, P2)

Method for the measurement of endocrine substances in an analyte

NOVEL USE OF G-PROTEIN-CONJUGATED RECEPTOR AND LIGAND THEREOF

Biological markers for longevity and diseases and uses thereof